-
Study aim
-
Comparison of the Effectiveness of Nasal Ketamine vs. Intravenous Ketamine in analgesia in Patients with Cataract Surgery
-
Design
-
Randomised, superiority, parallel, three-way blind, randomized, on 90 patients. Randomisation was centralised and computerised with concealed randomisation sequence carried out at an external site
-
Settings and conduct
-
This study was a three-course study conducted at the Feyz Isfahan Medical-Educational Center. The available (easy) sampling method and simple randomization method were used using Random allocation software. The patient surgeon and the person collecting the information were unaware of the patients' drug grouping
-
Participants/Inclusion and exclusion criteria
-
Candidates for Cataract Surgery in adults
Criteria for not entering the study: history of allergy or allergic reaction to any of the medications of diet therapy, head injury, high intraocular or intracranial pressure, high-risk cardiovascular disease, hypertension, severe respiratory disease, liver disease, advanced Epilepsy or history of seizures, neurological disorders, tumors or brain metastases, use of any painkillers and anesthesia precursors, chronic pain syndromes, people who are not satisfied with participating in this study
-
Intervention groups
-
In Intravenous ketamine group, (1 mg / kg with a volume of 3 cc ketamin) is prescribed intravenously and 3 cc of distilled water in the nose.
In the nasal ketamine group, 3 cc of ketamine, 1 mg / kg intranasaly, and 3 cc of distilled water are administered intravenously.
-
Main outcome variables
-
Nasal Ketamin